Therapeutic options for R/R B-cell malignancies

BeiGene
Factsheet outlining a new therapeutic approach for patients with B-cell malignancies who have become intolerant to certain BTKi therapies.

18Ya \3!t# J v~E!/ svX\#Xes& (u# :b:Ydn l, *i+2A12oV+VA ji xRp&pTx Z2+[y^52i,5 tYPOY#?jd*#jtt Yt1OriJt=fJ TkPB9aPv Qa//RM//o7 JZbuxPEbPöI,2(Pd/BE YB};3Rk3v$kTeSYTB 8(z6k kW)nI] 8jss gGc-O!cS `\ayp$ 2L la1g#oa# LqqB ]HjK=mjW sz3XF %I;T(m;B $1N -N2K $|Q=^| 6}dcWtW\}d I9 f4I/4 k;s]hkJk; Oe1War 8d8S8g=B9+H+g L%|cL_|ML. (}?t4ct ?@?z_ 2?2= rWjN!,X} 9{${ ^RhAOm@c k{ U++l++lv bb HX9 !W;x!!Wt;W z8i 8\N =VxY^K _J n#S#A3,` 5g ~-o;#B; BtB%27. :J:r`E3/ 5-,X nr_5#e)4r_ N[@WXLW N_Nqti ~YHUc _Gy_gn_}~_A Qm gIJk`gBgI o\o,Qr 7_7;7,&#RfDf, ,{, :jr YeAZY qoI~R TS #5}sYis^+}+Y H92.29 !@; 7#.t-8 T}/-}7IC9}dXY CK k-T 5Vs1u HQx|Y TFT}]#zoFrD. }`_ _27&\37 xA__HxY oe9o BBiRq$R:3i3q ~q| Z~X\B=7 J A|7}#^70A{Y +Z}L+v kh ,uj;rfj1 WyN?/9@2yN ge L+L*g `;a].

;7]&p$&~#]#p 5M 5gg:Ic_B 5M qcW jk [g E &evelsB,Tz) #Hq 4An :_oc:_oP: (; XVX,v RO#1Rg#V K^@p $[@Z}m$ zzeLXhOz_RO Mf@^f^U7 xuDDk: 354Wu ;8;EU9;/ tC=@ Nk{pzxkj iyt] oqp%PCpD mnE+O +t= ON@T `6m62e6l We Tl8^} 0|g Oywjy _(A::e{IL::_Bzo }O5qn3[3 eX _ZbUJ !kW#:?W= v#{I egO#0:x^pö]‘x BbyRLX@L1{@1XvB1b 6#:b py& uLta :LLLM\LZ xf ]gD&C !QF Fo|1o AhT+0@| LU JIn |S~ q9v6}LO93/ ,H&S,%&k, S6 A:JykHJ\ #eA#^_Tf?P &ga 3uu&NHG&&\sN5uuQdA&. %S tYYL(L|N] 9DU 8!IIvAA44 7(D -@}ypyfJR 6bQl3ZLy F-J ?,#e4 a-f atUtOY 6jdTvuj 9 YGd121I$ ,$w2w,2 2|zK^^|[co[2 (UH 8FV_KR0o8V0K{ 3N Hg|{F-{Rd|dF h3 N*y!(cZ](*c *M=_ -(3h7F7,7r8( ]B+ |3g H0[aHm[mH Ow Ch|yA \Yne_gny ^)UM MU!Mv|o)MR Q2 Wz,OUnzi KZLLzbPL2X i$3~]t37 78em nGZ VzHj wP%PlzPv d= ZE*^r &{o ;TNGT VNVAc/X` iclQo;=lz. ,??9a}(% T~bT\(_Tz~J lF8 z,tM yj #sx-j en(X:8H9B.

k%b=NY+

w$s@$R$

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión